XAF1
From Wikipedia, the free encyclopedia
XIAP associated factor-1
|
||||||||
Identifiers | ||||||||
Symbol(s) | XAF1; BIRC4BP; HSXIAPAF1 | |||||||
External IDs | OMIM: 606717 MGI: 3505735 HomoloGene: 49488 | |||||||
|
||||||||
RNA expression pattern | ||||||||
Orthologs | ||||||||
Human | Mouse | |||||||
Entrez | 54739 | 327959 | ||||||
Ensembl | ENSG00000132530 | ENSMUSG00000040483 | ||||||
Refseq | NM_017523 (mRNA) NP_059993 (protein) |
NM_001037713 (mRNA) NP_001032802 (protein) |
||||||
Location | Chr 17: 6.6 - 6.62 Mb | Chr 11: 72.12 - 72.13 Mb | ||||||
Pubmed search | [1] | [2] |
XIAP associated factor-1, also known as XAF1, is a human gene.[1]
X-linked inhibitor of apoptosis (XIAP; MIM 300079) is a potent member of the IAP family. All members of this family possess baculoviral IAP (BIR) repeats, cysteine-rich domains of approximately 80 amino acids that bind and inhibit caspases (e.g., CASP3; MIM 600636). XIAP has 3 BIR domains and a C-terminal RING zinc finger that possesses E3 ubiquitin ligase (see MIM 601623) activity. XAF1 antagonizes the anticaspase activity of XIAP and may be important in mediating apoptosis resistance in cancer cells (Liston et al., 2001).[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Fong WG, Liston P, Rajcan-Separovic E, et al. (2001). "Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines.". Genomics 70 (1): 113-22. doi: . PMID 11087668.
- Liston P, Fong WG, Kelly NL, et al. (2001). "Identification of XAF1 as an antagonist of XIAP anti-Caspase activity.". Nat. Cell Biol. 3 (2): 128-33. doi: . PMID 11175744.
- Leaman DW, Chawla-Sarkar M, Vyas K, et al. (2002). "Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.". J. Biol. Chem. 277 (32): 28504-11. doi: . PMID 12029096.
- Wistow G, Bernstein SL, Wyatt MK, et al. (2002). "Expressed sequence tag analysis of human retina for the NEIBank Project: retbindin, an abundant, novel retinal cDNA and alternative splicing of other retina-preferred gene transcripts.". Mol. Vis. 8: 196-204. PMID 12107411.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Byun DS, Cho K, Ryu BK, et al. (2004). "Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.". Cancer Res. 63 (21): 7068-75. PMID 14612497.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi: . PMID 14702039.
- Ng KC, Campos EI, Martinka M, Li G (2005). "XAF1 expression is significantly reduced in human melanoma.". J. Invest. Dermatol. 123 (6): 1127-34. doi: . PMID 15610524.
- Wang J, He H, Yu L, et al. (2006). "HSF1 down-regulates XAF1 through transcriptional regulation.". J. Biol. Chem. 281 (5): 2451-9. doi: . PMID 16303760.
- Yin W, Cheepala S, Clifford JL (2006). "Identification of a novel splice variant of X-linked inhibitor of apoptosis-associated factor 1.". Biochem. Biophys. Res. Commun. 339 (4): 1148-54. doi: . PMID 16343440.
- Fang X, Liu Z, Fan Y, et al. (2006). "Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor.". Int. J. Cancer 118 (10): 2485-9. doi: . PMID 16353137.
- Gilli F, Marnetto F, Caldano M, et al. (2006). "Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1.". Mult. Scler. 12 (1): 47-57. PMID 16459719.
- Reu FJ, Bae SI, Cherkassky L, et al. (2006). "Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.". J. Clin. Oncol. 24 (23): 3771-9. doi: . PMID 16801630.
- Lee MG, Huh JS, Chung SK, et al. (2006). "Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses.". Oncogene 25 (42): 5807-22. doi: . PMID 16909101.
- Zou B, Chim CS, Zeng H, et al. (2007). "Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.". Gastroenterology 131 (6): 1835-43. doi: . PMID 17087954.
- Micali OC, Cheung HH, Plenchette S, et al. (2007). "Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-beta.". BMC Cancer 7: 52. doi: . PMID 17376236.
- Kempkensteffen C, Hinz S, Schrader M, et al. (2007). "Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome.". Cancer Lett. 254 (2): 227-35. doi: . PMID 17449173.
- Shibata T, Mahotka C, Wethkamp N, et al. (2007). "Disturbed expression of the apoptosis regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas.". Diagn. Mol. Pathol. 16 (1): 1-8. doi: . PMID 17471152.
- Chung SK, Lee MG, Ryu BK, et al. (2007). "Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses.". Gastroenterology 132 (7): 2459-77. doi: . PMID 17570219.
- Arora V, Cheung HH, Plenchette S, et al. (2007). "Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.". J. Biol. Chem. 282 (36): 26202-9. doi: . PMID 17613533.